Akums Drugs & Pharmaceuticals Ltd declared the launch of Rabeprazole + Levosulpiride SR capsules. This new formulation, which was approved by the Drug Controller General of India (DCGI), aims to provide patients with better relief from disorders...
Essential Pharma, an international specialty pharmaceutical group dedicated to guaranteeing patients' long-term availability of low volume, clinically differentiated, niche pharmaceutical products across key therapeutic fields, declared that its...
Chugai Pharmaceutical Co, a drug manufacturer declared that the European Commission has sanctioned a Chugai originated anaplastic lymphoma kinase (ALK) inhibitor Alecensa monotherapy, as adjuvant treatment following growth resection for grown-up...
Akums Drugs & Pharmaceuticals Limited, known for its innovative approach to healthcare and pharmaceutical manufacturing, proudly concluded its series of Blood Donation Drives organized from June 5th to June 7th, 2024, across its widespread...
The U.S. Food and Drug Administration has granted advanced approval to the French drugmakers Ipsen and Genfit for their drug Iqirvo, which treats a chronic inflammatory liver disease called primary biliary cholangitis (PBC). PBC causes...
Hutchmed (China) Limited has started a phase I clinical trial of its menin inhibitor HMPL-506 in patients with haematological malignancies in China. The very first patient received their initial dose on May 31, 2024. This is a stage I...
.jpg)
